270 Private Capital Opportunities
About
What type of investor is 270 Private Capital Opportunities?
J.P. Morgan Life Sciences Private Capital is a venture capital and growth equity investment team within J.P. Morgan Asset Management. They focus on investing in private biotechnology companies, aiming to support innovative companies and guide them towards successful outcomes. Their early investments span areas like cardiometabolic disease, oncology, immunology, and genetic medicines.
What kind of firm is 270 Private Capital Opportunities?
270 Private Capital Opportunities is a Venture Capital.
What is 270 Private Capital Opportunities's assets under management?
270 Private Capital Opportunities manages approximately $677M in assets.
Where is 270 Private Capital Opportunities based?
270 Private Capital Opportunities is based in New York, USA.
What sectors does 270 Private Capital Opportunities focus on?
270 Private Capital Opportunities focuses on Biotechnology, Life Sciences.
Strength of the site’s backlink profile, on the industry-standard 0-100 scale. Licensed third-party data, not our opinion.
Check any domain freeStar ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.
No comments yet. Be the first to share your take.
